Begona Casis - Publications

Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.

Journal: Therapeutic advances in gastroenterology

Published: October 14, 2025

Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 07, 2024

Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU.

Journal: Therapeutic advances in gastroenterology

Published: November 16, 2023

Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis.

Journal: Alimentary pharmacology & therapeutics

Published: March 01, 2022

Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study.

Journal: Therapeutic advances in gastroenterology

Published: August 07, 2021

Current stage in inflammatory bowel disease: What is next?

Journal: World journal of gastroenterology

Published: June 01, 2015

Incidence, management, and course of cancer in patients with inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: February 18, 2015

Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units.

Journal: Journal of Crohn's & colitis

Published: September 06, 2013

Health care costs of complex perianal fistula in Crohn's disease.

Journal: Digestive diseases and sciences

Published: February 25, 2013

Infliximab-related hepatitis: a case study and literature review.

Journal: Digestive diseases and sciences

Published: February 05, 2013